Advertisement

Unique CDR3 epitope targeting by CAR-T is a viable approach for treating T cell malignancy

Unique CDR3 epitope targeting by CAR-T is a viable approach for treating T cell malignancy 曾子晏教授
廈門大學藥學院轉化醫學中心

malignancy

Post a Comment

0 Comments